Immediate Impact
1 by Nobel laureates 1 from Science/Nature 87 standout
Citing Papers
Lymph-node-targeted, mKRAS-specific amphiphile vaccine in pancreatic and colorectal cancer: the phase 1 AMPLIFY-201 trial
2024 Standout
Multi drug resistance in Colorectal Cancer- approaches to overcome, advancements and future success
2024 Standout
Works of Y. Humblet being referenced
Efficacy and circulating tumor DNA (ctDNA) analysis of the BRAF inhibitor dabrafenib (D), MEK inhibitor trametinib (T), and anti-EGFR antibody panitumumab (P) in patients (pts) with BRAF V600E–mutated (BRAFm) metastatic colorectal cancer (mCRC)
2016
10LBA Randomized phase 3 study of panitumumab with FOLFOX4 compared to FOLFOX4 alone as 1st-line treatment (tx) for metastatic colorectal cancer (mCRC): the PRIME trial
2009
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| Y. Humblet | 110 | 53 | 27 | 48 | 9 | 116 | |
| Fengjiao Zhao | 92 | 46 | 38 | 31 | 14 | 141 | |
| C.-H. Köhne | 128 | 46 | 32 | 28 | 12 | 140 | |
| Hirokazu Mizuguchi | 90 | 56 | 19 | 34 | 11 | 142 | |
| Dominique Auby | 171 | 61 | 61 | 38 | 11 | 207 | |
| K. Azuma | 50 | 77 | 35 | 24 | 7 | 114 | |
| Y.S. Park | 111 | 70 | 15 | 30 | 12 | 143 | |
| Valentina Pomella | 91 | 34 | 27 | 35 | 7 | 97 | |
| Jo Dent | 148 | 76 | 32 | 20 | 9 | 175 | |
| Catherine Leger | 196 | 88 | 25 | 70 | 10 | 232 | |
| Loïck Vidot | 189 | 69 | 23 | 73 | 11 | 228 |
All Works
Loading papers...